Member of the Association of American Physicians
David A. Kass mainly focuses on Internal medicine, Cardiology, Heart failure, Endocrinology and Ejection fraction. His study in Internal medicine focuses on Diastole, Contractility, Dilated cardiomyopathy, Circulatory system and Inotrope. His Cardiology study incorporates themes from Blood pressure, Heart rate and Systole.
His work carried out in the field of Heart failure brings together such families of science as QRS complex, Heart disease and Sudden death. His Heart disease study combines topics in areas such as Ventricular tachycardia, Randomized controlled trial and Intensive care medicine. His work in Endocrinology tackles topics such as Phosphodiesterase which are related to areas like cGMP-dependent protein kinase, Signal transduction and Stimulation.
His primary scientific interests are in Internal medicine, Cardiology, Heart failure, Endocrinology and Ejection fraction. His Internal medicine research focuses on Diastole, Cardiac resynchronization therapy, Myocyte, Hemodynamics and Contractility. In his work, Anesthesia is strongly intertwined with Blood pressure, which is a subfield of Cardiology.
His Heart failure research is multidisciplinary, incorporating elements of Circulatory system and Heart disease. His Endocrinology research includes elements of cGMP-dependent protein kinase and Signal transduction. He interconnects Phosphodiesterase and cGMP-specific phosphodiesterase type 5 in the investigation of issues within cGMP-dependent protein kinase.
His main research concerns Internal medicine, Cardiology, Heart failure, Heart failure with preserved ejection fraction and Cell biology. His biological study spans a wide range of topics, including Diabetes mellitus and Endocrinology. His Endocrinology research incorporates elements of Signal transduction and Downregulation and upregulation.
In his study, which falls under the umbrella issue of Cardiology, Sarcomere and Idiopathic Pulmonary Arterial Hypertension is strongly linked to Myofilament. His research integrates issues of Muscle hypertrophy, Cyclic guanosine monophosphate, Human heart and Pharmacology in his study of Heart failure. His research investigates the connection with Heart failure with preserved ejection fraction and areas like Dopamine which intersect with concerns in Right ventricular dysfunction.
David A. Kass mostly deals with Internal medicine, Heart failure, Cardiology, Cell biology and Ejection fraction. His study looks at the intersection of Internal medicine and topics like Endocrinology with Natriuretic peptide. The study incorporates disciplines such as PDE1, Pharmacology, Diuretic and Furosemide in addition to Heart failure.
His Cardiology research is multidisciplinary, relying on both Diuresis and Creatinine. The various areas that David A. Kass examines in his Cell biology study include S-Nitrosylation, Phosphodiesterase, Proteolysis and Calpain. His Ejection fraction research incorporates themes from Cardiomyopathy, Signal transduction, Gene expression and Human heart.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
Michael R Bristow;LA Leslie A Saxon;John Boehmer;Steven Krueger.
The New England Journal of Medicine (2004)
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Susan J. Zieman;Vojtech Melenovsky;David A. Kass.
Arteriosclerosis, Thrombosis, and Vascular Biology (2005)
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure Validation of Generalized Transfer Function
C.-H. Chen;E. Nevo;B. Fetics;P. H. Pak.
Circulation (1997)
Improved Left Ventricular Mechanics From Acute VDD Pacing in Patients With Dilated Cardiomyopathy and Ventricular Conduction Delay
David A. Kass;Chen Huan Chen;Cecilia Curry;Maurice Talbot.
Circulation (1999)
Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials.
David J. Bradley;Elizabeth A. Bradley;Elizabeth A. Bradley;Kenneth L. Baughman;Kenneth L. Baughman;Ronald D. Berger.
JAMA (2003)
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction. Implications for Systolic and Diastolic Reserve Limitations
Miho Kawaguchi;Ilan Hay;Barry Fetics;David A. Kass.
Circulation (2003)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Eiki Takimoto;Hunter C Champion;Manxiang Li;Diego Belardi.
Nature Medicine (2005)
Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block
Gregory S. Nelson;Ronald D. Berger;Barry J. Fetics;Maurice Talbot.
Circulation (2000)
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
David A. Kass;Edward P. Shapiro;Miho Kawaguchi;Anne R. Capriotti.
Circulation (2001)
Effective arterial elastance as index of arterial vascular load in humans.
R P Kelly;C T Ting;T M Yang;C P Liu.
Circulation (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Mercer University
Cedars-Sinai Medical Center
University of Miami
Mayo Clinic
Johns Hopkins University
Cedars-Sinai Medical Center
Tufts Medical Center
Medical University of South Carolina
Johns Hopkins University School of Medicine
Ambiq Micro
Chonnam National University
Ajou University
University of Georgia
University of Delaware
University of Oxford
Monash University
Agricultural University of Athens
University of Genoa
Institut de Physique du Globe de Paris
University of Göttingen
University of Limerick
University of Sydney
Yale University
National Institutes of Health
Harvard University